[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
PubMed=11683410 [NCBI, ExPASy, EBI, Israel, Japan]
Bell S.E.,
Mavila A.,
Salazar R.,
Bayless K.J.,
Kanagala S.,
Maxwell S.A.,
Davis G.E.;
"Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.";
J. Cell Sci. 114:2755-2773(2001).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH ANTHRAX TOXIN.
TISSUE=Placenta;
DOI=10.1073/pnas.0431098100; PubMed=12700348 [NCBI, ExPASy, EBI, Israel, Japan]
Scobie H.M.,
Rainey G.J.A.,
Bradley K.A.,
Young J.A.T.;
"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.";
Proc. Natl. Acad. Sci. U.S.A. 100:5170-5174(2003).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 78-489 (ISOFORM 3), AND VARIANT ALA-357.
TISSUE=Synovial cell;
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T.,
Suzuki Y.,
Nishikawa T.,
Otsuki T.,
Sugiyama T.,
Irie R.,
Wakamatsu A.,
Hayashi K.,
Sato H.,
Nagai K.,
Kimura K.,
Makita H.,
Sekine M.,
Obayashi M.,
Nishi T.,
Shibahara T.,
Tanaka T.,
Ishii S.,
Yamamoto J., ![]()
Saito K.,
Kawai Y.,
Isono Y.,
Nakamura Y.,
Nagahari K.,
Murakami K.,
Yasuda T.,
Iwayanagi T.,
Wagatsuma M.,
Shiratori A.,
Sudo H.,
Hosoiri T.,
Kaku Y.,
Kodaira H.,
Kondo H.,
Sugawara M.,
Takahashi M.,
Kanda K.,
Yokoi T.,
Furuya T.,
Kikkawa E.,
Omura Y.,
Abe K.,
Kamihara K.,
Katsuta N.,
Sato K.,
Tanikawa M.,
Yamazaki M.,
Ninomiya K.,
Ishibashi T.,
Yamashita H.,
Murakawa K.,
Fujimori K.,
Tanai H.,
Kimata M.,
Watanabe M.,
Hiraoka S.,
Chiba Y.,
Ishida S.,
Ono Y.,
Takiguchi S.,
Watanabe S.,
Yosida M.,
Hotuta T.,
Kusano J.,
Kanehori K.,
Takahashi-Fujii A.,
Hara H.,
Tanase T.-O.,
Nomura Y.,
Togiya S.,
Komai F.,
Hara R.,
Takeuchi K.,
Arita M.,
Imose N.,
Musashino K.,
Yuuki H.,
Oshima A.,
Sasaki N.,
Aotsuka S.,
Yoshikawa Y.,
Matsunawa H.,
Ichihara T.,
Shiohata N.,
Sano S.,
Moriya S.,
Momiyama H.,
Satoh N.,
Takami S.,
Terashima Y.,
Suzuki O.,
Nakagawa S.,
Senoh A.,
Mizoguchi H.,
Goto Y.,
Shimizu F.,
Wakebe H.,
Hishigaki H.,
Watanabe T.,
Sugiyama A.,
Takemoto M.,
Kawakami B.,
Yamazaki M.,
Watanabe K.,
Kumagai A.,
Itakura S.,
Fukuzumi Y.,
Fujimori Y.,
Komiyama M.,
Tashiro H.,
Tanigami A.,
Fujiwara T.,
Ono T.,
Yamada K.,
Fujii Y.,
Ozaki K.,
Hirao M.,
Ohmori Y.,
Kawabata A.,
Hikiji T.,
Kobatake N.,
Inagaki H.,
Ikema Y.,
Okamoto S.,
Okitani R.,
Kawakami T.,
Noguchi S.,
Itoh T.,
Shigeta K.,
Senba T.,
Matsumura K.,
Nakajima Y.,
Mizuno T.,
Morinaga M.,
Sasaki M.,
Togashi T.,
Oyama M.,
Hata H.,
Watanabe M.,
Komatsu T.,
Mizushima-Sugano J.,
Satoh T.,
Shirai Y.,
Takahashi Y.,
Nakagawa K.,
Okumura K.,
Nagase T.,
Nomura N.,
Kikuchi H.,
Masuho Y.,
Yamashita R.,
Nakai K.,
Yada T.,
Nakamura Y.,
Ohara O.,
Isogai T.,
Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
TISSUE=Aortic endothelium;
Totoki Y.,
Toyoda A.,
Takeda T.,
Sakaki Y.,
Tanaka A.,
Yokoyama S.,
Ohara O.,
Nagase T.,
Kikuno F.R.;
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 137-489 (ISOFORM 4), AND VARIANT ALA-357.
TISSUE=Lymph node;
The German cDNA consortium;
Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 248-489 (ISOFORM 4).
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
INTERACTION WITH ANTHRAX TOXIN, AND CLATHRIN-DEPENDENT INTERNALIZATION.
DOI=10.1083/jcb.200211018; PubMed=12551953 [NCBI, ExPASy, EBI, Israel, Japan]
Abrami L.,
Liu S.,
Cosson P.,
Leppla S.H.,
van der Goot F.G.;
"Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process.";
J. Cell Biol. 160:321-328(2003).
|
[8]
|
INTERNALIZATION.
DOI=10.1083/jcb.200312072; PubMed=15337774 [NCBI, ExPASy, EBI, Israel, Japan]
Abrami L.,
Lindsay M.,
Parton R.G.,
Leppla S.H.,
van der Goot F.G.;
"Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway.";
J. Cell Biol. 166:645-651(2004).
|
[9]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 40-212 OF COMPLEX WITH THE PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS.
DOI=10.1038/nature02763; PubMed=15243628 [NCBI, ExPASy, EBI, Israel, Japan]
Santelli E.,
Bankston L.A.,
Leppla S.H.,
Liddington R.C.;
"Crystal structure of a complex between anthrax toxin and its host cell receptor.";
Nature 430:905-908(2004).
|
[10]
|
X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 38-217.
DOI=10.1073/pnas.0401506101; PubMed=15079089 [NCBI, ExPASy, EBI, Israel, Japan]
Lacy D.B.,
Wigelsworth D.J.,
Scobie H.M.,
Young J.A.T.,
Collier R.J.;
"Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.";
Proc. Natl. Acad. Sci. U.S.A. 101:6367-6372(2004).
|
[11]
|
X-RAY CRYSTALLOGRAPHY (3.6 ANGSTROMS) OF 38-218 OF COMPLEX WITH THE PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS.
DOI=10.1073/pnas.0405405101; PubMed=15326297 [NCBI, ExPASy, EBI, Israel, Japan]
Lacy D.B.,
Wigelsworth D.J.,
Melnyk R.A.,
Harrison S.C.,
Collier R.J.;
"Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.";
Proc. Natl. Acad. Sci. U.S.A. 101:13147-13151(2004).
|
[12]
|
VARIANTS ISH PRO-45; THR-189 AND ARG-218, VARIANTS JHF GLN-293 INS AND CYS-381, VARIANT ALA-357, AND TISSUE SPECIFICITY.
DOI=10.1086/378418; PubMed=14508707 [NCBI, ExPASy, EBI, Israel, Japan]
Hanks S.,
Adams S.,
Douglas J.,
Arbour L.,
Atherton D.J.,
Balci S.,
Bode H.,
Campbell M.E.,
Feingold M.,
Keser G.,
Kleijer W.,
Mancini G.,
McGrath J.A.,
Muntoni F.,
Nanda A.,
Teare M.D.,
Warman M.,
Pope F.M.,
Superti-Furga A., ![]()
Futreal P.A.,
Rahman N.;
"Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis.";
Am. J. Hum. Genet. 73:791-800(2003).
|
[13]
|
VARIANT ISH THR-189, VARIANTS JHF ASP-105 AND ARG-329, AND FUNCTION.
DOI=10.1086/378781; PubMed=12973667 [NCBI, ExPASy, EBI, Israel, Japan]
Dowling O.,
Difeo A.,
Ramirez M.C.,
Tukel T.,
Narla G.,
Bonafe L.,
Kayserili H.,
Yuksel-Apak M.,
Paller A.S.,
Norton K.,
Teebi A.S.,
Grum-Tokars V.,
Martin G.S.,
Davis G.E.,
Glucksman M.J.,
Martignetti J.A.;
"Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.";
Am. J. Hum. Genet. 73:957-966(2003).
|
[14]
|
INVOLVEMENT IN INFANTILE SYSTEMIC HYALINOSIS.
DOI=10.1111/j.1365-2230.2004.01698.x; PubMed=15725249 [NCBI, ExPASy, EBI, Israel, Japan]
Lee J.Y.-Y.,
Tsai Y.-M.,
Chao S.-C.,
Tu Y.-F.;
"Capillary morphogenesis gene-2 mutation in infantile systemic hyalinosis: ultrastructural study and mutation analysis in a Taiwanese infant.";
Clin. Exp. Dermatol. 30:176-179(2005).
|
|
ExPASy Home page
SIB Switzerland
